PRHSX T. Rowe Price Health Sciences Fund

This is an open ended mutual fund. The investment seeks long-term capital appreciation. The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed health sciences ). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. It is non-diversified.

As of 08/14/2022

Mutual Fund Information
Sponsor:     T. Rowe Price Funds
Category1:  US Equity
Category2:  Single sector
Category3:  Health care
Morningstar category:  Health
Investment style: Actively managed
Leverage factor:  1.00
Inception date:     12/29/1995
Market cap:     $11,394,010,000
Current yield:     0.00%
Fees:     0.7700%
All SEC Filings:  SEC Edgar Online
Summary Prospectus:  497
Semi-Annual filings:  N-CSR
Quarterly holdings:  NPORT
Investment style: Actively managed

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy